August 1st, 2013
•The most commonly used method for generating large numbers of autologous dendritic cells (DCs) for use in tumor immunotherapy is described. The method uses IL-4 and GM-CSF to differentiate DCs from monocytes. The immature DCs are stimulated to mature and then loaded with antigens before they are injected back into the patient.
Tags
Related Videos
Murine Model of CD40-activation of B cells
Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation
Isolation of Mouse Lung Dendritic Cells
Isolation of Myeloid Dendritic Cells and Epithelial Cells from Human Thymus
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
A CFSE-based Assay to Study the Migration of Murine Skin Dendritic Cells into Draining Lymph Nodes During Infection with Mycobacterium bovis Bacille Calmette-Guérin
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved